BSE Prices delayed by 5 minutes... << Prices as on Aug 04, 2025 >>   ABB  5092.5 ATS - Market Arrow  [-5.65]  ACC  1790.15 ATS - Market Arrow  [-0.22]  AMBUJA CEM  605.1 ATS - Market Arrow  [-0.64]  ASIAN PAINTS  2449.75 ATS - Market Arrow  [0.84]  AXIS BANK  1068.45 ATS - Market Arrow  [0.55]  BAJAJ AUTO  8184.55 ATS - Market Arrow  [1.79]  BANKOFBARODA  241.2 ATS - Market Arrow  [2.59]  BHARTI AIRTE  1915.05 ATS - Market Arrow  [1.59]  BHEL  241.4 ATS - Market Arrow  [4.23]  BPCL  317.85 ATS - Market Arrow  [0.08]  BRITANIAINDS  5785.2 ATS - Market Arrow  [-0.31]  CIPLA  1515.45 ATS - Market Arrow  [0.95]  COAL INDIA  374.75 ATS - Market Arrow  [0.63]  COLGATEPALMO  2253.45 ATS - Market Arrow  [-0.13]  DABUR INDIA  529.45 ATS - Market Arrow  [-0.82]  DLF  793.65 ATS - Market Arrow  [2.12]  DRREDDYSLAB  1225.4 ATS - Market Arrow  [0.48]  GAIL  174.65 ATS - Market Arrow  [0.20]  GRASIM INDS  2788.2 ATS - Market Arrow  [2.42]  HCLTECHNOLOG  1474.3 ATS - Market Arrow  [1.47]  HDFC BANK  1992.25 ATS - Market Arrow  [-0.99]  HEROMOTOCORP  4534.45 ATS - Market Arrow  [5.14]  HIND.UNILEV  2541.55 ATS - Market Arrow  [-0.38]  HINDALCO  687.7 ATS - Market Arrow  [2.31]  ICICI BANK  1463 ATS - Market Arrow  [-0.57]  INDIANHOTELS  749.45 ATS - Market Arrow  [1.16]  INDUSINDBANK  803.9 ATS - Market Arrow  [2.58]  INFOSYS  1480.35 ATS - Market Arrow  [0.66]  ITC LTD  416.65 ATS - Market Arrow  [0.04]  JINDALSTLPOW  980.5 ATS - Market Arrow  [3.75]  KOTAK BANK  1996.95 ATS - Market Arrow  [0.24]  L&T  3630.05 ATS - Market Arrow  [1.13]  LUPIN  1883 ATS - Market Arrow  [0.94]  MAH&MAH  3200 ATS - Market Arrow  [1.26]  MARUTI SUZUK  12363.85 ATS - Market Arrow  [0.52]  MTNL  45.38 ATS - Market Arrow  [-0.70]  NESTLE  2277.35 ATS - Market Arrow  [0.06]  NIIT  121.95 ATS - Market Arrow  [7.49]  NMDC  71.89 ATS - Market Arrow  [2.06]  NTPC  332.1 ATS - Market Arrow  [0.38]  ONGC  234.95 ATS - Market Arrow  [-0.80]  PNB  104.65 ATS - Market Arrow  [1.45]  POWER GRID  288 ATS - Market Arrow  [-1.10]  RIL  1411.3 ATS - Market Arrow  [1.27]  SBI  795.65 ATS - Market Arrow  [0.21]  SESA GOA  431.2 ATS - Market Arrow  [1.61]  SHIPPINGCORP  211.3 ATS - Market Arrow  [0.38]  SUNPHRMINDS  1641 ATS - Market Arrow  [0.73]  TATA CHEM  974.65 ATS - Market Arrow  [1.91]  TATA GLOBAL  1072 ATS - Market Arrow  [0.19]  TATA MOTORS  653.65 ATS - Market Arrow  [0.76]  TATA STEEL  159.6 ATS - Market Arrow  [4.31]  TATAPOWERCOM  387.05 ATS - Market Arrow  [-0.58]  TCS  3074.9 ATS - Market Arrow  [2.39]  TECH MAHINDR  1475.45 ATS - Market Arrow  [2.53]  ULTRATECHCEM  12252.85 ATS - Market Arrow  [1.22]  UNITED SPIRI  1339.55 ATS - Market Arrow  [1.30]  WIPRO  246.05 ATS - Market Arrow  [1.34]  ZEETELEFILMS  119.15 ATS - Market Arrow  [2.41]  

Advanced Enzyme Technologies Ltd.

Auditor Report

NSE: ADVENZYMESEQ BSE: 540025ISIN: INE837H01020INDUSTRY: Pharmaceuticals

BSE   Rs 328.60   Open: 356.25   Today's Range 318.65
356.25
 
NSE
Rs 328.75
-31.60 ( -9.61 %)
-31.65 ( -9.63 %) Prev Close: 360.25 52 Week Range 257.85
571.15
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 3678.09 Cr. P/BV 2.74 Book Value (Rs.) 119.92
52 Week High/Low (Rs.) 571/258 FV/ML 2/1 P/E(X) 28.05
Bookclosure 23/07/2025 EPS (Rs.) 11.72 Div Yield (%) 1.58
Year End :2025-03 

We have audited the accompanying standalone financial
statements of Advanced Enzyme Technologies Limited (“the
Company”), which comprise the Balance Sheet as at March
31, 2025, and the Statement of Profit and Loss, including
Other Comprehensive Income, Statement of Changes in
Equity and Statement of Cash Flows for the year then ended,
and notes to the standalone financial statements, including
material accounting policy information and other explanatory
information (hereinafter referred to as the “standalone financial
statements”).

In our opinion and to the best of our information and according to
the explanations given to us, the aforesaid standalone financial
statements give the information required by the Companies Act,
2013 (“the Act’) in the manner so required and give a true and
fair view in conformity with the Indian Accounting Standards
prescribed under section 133 of the Act read with Companies
(Indian Accounting Standards) Rules, 2015, as amended (“Ind
AS”) and other accounting principles generally accepted in
India, of the state of affairs of the Company as at March 31, 2025,
and profit (including other comprehensive income), changes in
equity and its cash flows for the year ended on that date.

Basis for Opinion

We conducted our audit of the standalone financial statements
in accordance with the Standards on Auditing (SAs) specified
under section 143(10) of the Act. Our responsibilities under
those Standards are further described in the ‘Auditor’s
Responsibilities for the Audit of the Standalone Financial
Statements’ section of our report. We are independent of the
Company in accordance with the Code of Ethics issued by the
Institute of Chartered Accountants of India (“ICAI”) together
with the ethical requirements that are relevant to our audit of
the standalone financial statements under the provisions of the
Act and the Rules thereunder, and we have fulfilled our other
ethical responsibilities in accordance with these requirements
and the Code of Ethics. We believe that the audit evidence
obtained by us is sufficient and appropriate to provide a basis
for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional
judgment, were of most significance in our audit of the
standalone financial statements for the year ended March 31,
2025. These matters were addressed in the context of our audit
of the standalone financial statements as a whole, and in forming
our opinion thereon, and we do not provide a separate opinion
on these matters. We have determined the matters described
below to be the key audit matters to be communicated in our
report.

See Note 49 of Standalone Financial Statements

Sr.

No

Key Audit Matters

How the Key Audit Matters was addressed in our audit

1

During the year, the Company has made an additional
investment of H 478.18 million in its wholly owned
subsidiary - Advanced Enzymes Europe B.V. (AEEBV),
post which the carrying value of investment in AEEBV
is H 772.25 million (net of provision for impairment
amounting to H 189.48 million) as on March 31, 2025.
AEEBV has further investment in Evoxx Technologies
GmbH (Evoxx) (taken together as AEEBV group)

AEEBV Group has been making operational losses and
has cash outflows from its operating activities.

Management of the Company has performed
an impairment assessment in relation to such
Investment as per the requirements of Ind AS 36
"Impairment of Assets" and has determined that no
additional impairment provision is to be considered in
the current year.

In regard to the impairment testing on its investments,
the determination of the fair value of the AEEBV group
requires management of the Company to estimate
significant assumptions including future revenue and
terminal growth rates apart from margin assumptions
and discount rates to estimate future cash flows.
Given the past impairment, the history of losses,
and the reliance on forward-looking estimates, we
have identified the impairment assessment of the
investment in the subsidiary as a key audit matter.

Our audit procedures to address the impairment of Investments

included and were not limited to the following:

1. Obtained an understanding from the Management of the
Company with respect to policies and procedures followed by
the Management with respect to measurement and testing of
impairment on the Company’s Investment in AEEBV group.

2. Reviewed valuation reports of AEEBV group issued by registered
valuer and provided by the management of the Company.

3. Assessed the reasonableness of inputs used in the valuation
report provided by management for the future revenue and margin
projections, the accuracy of the cash flow forecasts and analyzed
the underlying key assumptions, including discounting rates and
terminal growth rates.

4. Compared the reasonableness of future operating cash flow
forecasts with the business plan and tested the mathematical
accuracy of management’s calculations.

5. Involved our internal experts to assess the consistency and
reasonableness of the Company’s valuation methodology
and assumptions, applied in determining the fair value of the
subsidiary, in order to assess related impairment on investment
made in subsidiary.

6. Compared the recoverable value and carrying value and concluded
that recoverable value is in excess of carrying value and hence,
impairment is not required.

Information Other than the Standalone Financial Statements
and Auditor's Report Thereon

The Company’s Board of Directors is responsible for the other
information. The other information comprises the information
included in the Company’s annual report but does not include
the standalone financial statements and our auditor’s report
thereon, which we obtained prior to the date of this auditor’s
report, and the Company’s annual report, which is expected to
be made available to us after that date.

Our opinion on the standalone financial statements does not
cover the other information and we do not and will not express
any form of assurance conclusion thereon.

In connection with our audit of the standalone financial
statements, our responsibility is to read the other information
identified above and, in doing so, consider whether the other
information is materially inconsistent with the standalone
financial statements or our knowledge obtained in the audit,
or otherwise appears to be materially misstated. If, based on
the work we have performed on the other information that we
obtained prior to the date of this auditor’s report, we conclude
that there is a material misstatement of this other information,
we are required to report that fact. We have nothing to report in
this regard.

When we read the Company’s annual report, if we conclude
that there is a material misstatement therein, we are required
to communicate the matter to those charged with governance
under SA 720 ‘The Auditor’s responsibilities Relating to Other
Information’ and take necessary action under the relevant laws
and regulations

Responsibilities of Management and Those Charged with
Governance for the Standalone Financial Statements

The Company’s Board of Directors is responsible for the matters
stated in section 134(5) of the Act with respect to the preparation
of these standalone financial statements that give a true and fair
view of the financial position, financial performance, changes in
equity and cash flows of the Company in accordance with the
accounting principles generally accepted in India, including
the Accounting Standards specified under section 133 of the
Act. This responsibility also includes maintenance of adequate
accounting records in accordance with the provisions of the Act
for safeguarding of the assets of the Company and for preventing
and detecting frauds and other irregularities; selection
and application of appropriate accounting policies; making
judgments and estimates that are reasonable and prudent; and
design, implementation and maintenance of adequate internal
financial controls, that were operating effectively for ensuring
the accuracy and completeness of the accounting records,
relevant to the preparation and presentation of the standalone
financial statement that give a true and fair view and are free
from material misstatement, whether due to fraud or error.

In preparing the standalone financial statements, the
Management and Board of Directors are responsible for
assessing the Company’s ability to continue as a going concern,
disclosing, as applicable, matters related to going concern and
using the going concern basis of accounting unless the Board
of Directors either intends to liquidate the Company or to cease
operations, or has no realistic alternative but to do so.

The Board of Directors are also responsible for overseeing the
Company’s financial reporting process.

Auditor's Responsibilities for the Audit of the Standalone
Financial Statements

Our objectives are to obtain reasonable assurance about whether
the standalone financial statements as a whole are free from
material misstatement, whether due to fraud or error, and to
issue an auditor’s report that includes our opinion. Reasonable
assurance is a high level of assurance, but is not a guarantee that
an audit conducted in accordance with SAs will always detect a
material misstatement when it exists. Misstatements can arise
from fraud or error and are considered material if, individually or
in the aggregate, they could reasonably be expected to influence
the economic decisions of users taken on the basis of these
standalone financial statements.

We give in “Annexure A” a detailed description of Auditor’s
responsibilities for Audit of the Standalone Financial
Statements.

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor’s Report) Order,
2020 (“the Order”), issued by the Central Government of
India in terms of sub-section (11) of section 143 of the
Act, we give in “Annexure B” a statement on the matters
specified in paragraphs 3 and 4 of the Order, to the extent
applicable.

2. As required by Section 143(3) of the Act, we report that:

(a) We have sought and obtained all the information and
explanations which to the best of our knowledge and
belief were necessary for the purposes of our audit.

(b) I n our opinion, proper books of account as required
by law have been kept by the Company so far as it
appears from our examination of those books.

(c) The Balance Sheet, the Statement of Profit and
Loss including other comprehensive income, the
Statement of Changes in Equity and the Statement of
Cash Flow dealt with by this Report are in agreement
with the books of account.

(d) In our opinion, the aforesaid standalone financial
statements comply with the Accounting Standards
specified under Section 133 of the Act.

(e) On the basis of the written representations received
from the directors as on March 31, 2025 taken on
record by the Board of Directors, none of the directors
are disqualified as on March 31, 2025 from being
appointed as a director in terms of Section 164 (2) of
the Act.

(f) With respect to the adequacy of the internal financial
controls with reference to standalone financial
statements of the Company and the operating
effectiveness of such controls, refer to our separate
Report in “Annexure C”.

(g) With respect to the other matters to be included in
the Auditor’s Report in accordance with Rule 11 of
the Companies (Audit and Auditors) Rules, 2014, in
our opinion and to the best of our information and
according to the explanations given to us:

i. The Company has disclosed the impact of
pending litigations on its financial position in its
standalone financial statements - Refer Note 53
to the standalone financial statements;

ii. The Company did not have any long-term
contracts including derivative contracts for
which there were any material foreseeable
losses.

iii. There has been no delay in transferring amounts,
required to be transferred, to the Investor
Education and Protection Fund by the Company.

iv.

1) The Management has represented that,
to the best of its knowledge and belief,
no funds have been advanced or loaned
or invested (either from borrowed funds
or share premium or any other sources
or kind of funds) by the Company to or in
any other persons or entities, including
foreign entities (“Intermediaries”), with the
understanding, whether recorded in writing
or otherwise, that the Intermediary shall,
directly or indirectly lend or invest in other
persons or entities identified in any manner
whatsoever by or on behalf of the Company
(“Ultimate Beneficiaries”) or provide any
guarantee, security or the like on behalf of
the Ultimate Beneficiaries.

2) The Management has represented, that,
to the best of its knowledge and belief, no
funds have been received by the Company
from any persons or entities, including
foreign entities (Funding Parties), with
the understanding, whether recorded in
writing or otherwise, as on the date of
this audit report, that the Company shall,
directly or indirectly, lend or invest in other
persons or entities identified in any manner
whatsoever by or on behalf of the Funding
Party (“Ultimate Beneficiaries”) or provide
any guarantee, security or the like on behalf
of the Ultimate Beneficiaries.

3) Based on the audit procedures performed
that have been considered reasonable
and appropriate in the circumstances,
and according to the information and
explanations provided to us by the
Management in this regard nothing has
come to our notice that has caused us to
believe that the representations under
sub-clause (i) and (ii) of Rule 11(e) as
provided under (1) and (2) above, contain
any material mis-statement.

v.

1) The interim dividend declared and paid by
the Company during the year and until the
date of this audit report is in accordance
with section 123 of the Companies Act
2013.

2) The final dividend paid by the Company
during the year in respect of the same
declared for the previous year is in
accordance with section 123 of the
Companies Act 2013 to the extent it applies
to payment of dividend.

3) The Board of Directors of the Company have
proposed final dividend for the year which
is subject to the approval of the members
at the ensuing Annual General Meeting. The
dividend declared is in accordance with
section 123 of the Act to the extent it applies
to declaration of dividend. (Refer Note 50 to
the Standalone financial statements)

vi. Based on our examination, the Company has
used an accounting software for maintaining
its books of account which has a feature of
recording audit trail (edit log) facility. The audit
trail feature has been operated throughout
the year for all transactions recorded in the
accounting software. Further, during the course
of our audit, we did not come across any instance
of the audit trail feature being tampered with.

3. In our opinion, according to information, explanations
given to us, the remuneration paid by the Company to
its directors is within the limits laid prescribed under
Section 197 read with Schedule V of the Act and the
rules thereunder.

For M S K A & Associates
Chartered Accountants

ICAI Firm Registration No. 105047W

Amrish Vaidya

Partner

Membership No. 101739
UDIN: 25101739BMIKFC2197

Place: Mumbai
Date: May 13, 2025

 
STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z|Others

Mutual Fund A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

Registered Office : 402, Nirmal Towers, Dwarakapuri Colony, Punjagutta, Hyderabad - 500082.
SEBI Registration No's: NSE / BSE / MCX : INZ000166638. Depository Participant: IN- DP-224-2016.
AMFI Registered Number - 29900 (ARN valid upto 24th July 2025) - AMFI-Registered Mutual Fund Distributor since June 2008.
Compliance Officer :- Name: Ch.V.A. Varaprasad, Mobile No.: 9393136201, E-mail: varaprasad.challa@rlpsec.com
Grievance Cell: rlpsec_grievancecell@yahoo.com , rlpdp_grievancecell@yahoo.com
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Copyrights @ 2014 © RLP Securities. All Right Reserved Designed, developed and content provided by